Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

5.4K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
5.4K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

582
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
582
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

2.3K
The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
2.3K
Infertility in Females01:28

Infertility in Females

3.4K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
3.4K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

1.1K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.1K
Hormonal Regulation01:40

Hormonal Regulation

46.2K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
46.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fertility-sparing treatment of women with endometrial carcinoma with myometrial invasion: pooled estimates of response from a systematic review and meta-analysis.

Journal of minimally invasive gynecology·2026
Same author

Central sensitization and hormonal therapy failure for endometriosis-related pain symptoms: a prospective study.

Journal of minimally invasive gynecology·2026
Same author

Prevalence of urinary symptoms in women with parametrial endometriosis - Systematic review and meta-analysis.

Journal of minimally invasive gynecology·2026
Same author

Breast Cancer and Ovarian Tissue Cryopreservation: SWOT Analysis.

Journal of clinical medicine·2026
Same author

Impact of ovarian preservation on survival for premenopausal women with early-stage endometrial carcinoma: A systematic review and meta-analysis.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Prolonged conservative treatment of women with atypical endometrial hyperplasia and early endometrial carcinoma: A systematic review and meta-analysis.

European journal of obstetrics, gynecology, and reproductive biology·2026

Related Experiment Video

Updated: Nov 18, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.1K

Contraception across transgender.

Ilaria Mancini1, Stefania Alvisi2, Giulia Gava2

  • 1Gynecology and Physiopathology of Human Reproduction, S. Orsola-Malpighi Hospital, Department of Medical and Surgical Sciences (DIMEC), IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Bologna, Italy. mancini.ilaria89@gmail.com.

International Journal of Impotence Research
|February 9, 2021
PubMed
Summary
This summary is machine-generated.

Gender-affirming hormonal treatments (GAHTs) can impact fertility in transgender individuals. Counseling on contraception and reproductive risks is crucial before and during GAHT to prevent unintended pregnancies.

More Related Videos

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

1.8K
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.3K

Related Experiment Videos

Last Updated: Nov 18, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.1K
Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
07:37

Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids

Published on: August 16, 2024

1.8K
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.3K

Area of Science:

  • Endocrinology
  • Reproductive Health
  • Gender Studies

Background:

  • Sexual and reproductive health are vital for transgender well-being.
  • Gender-affirming hormonal treatments (GAHTs) aim to align physical traits with gender identity, reducing dysphoria.
  • While surgeries cause permanent infertility, hormonal treatments may lead to reversible fertility loss.

Purpose of the Study:

  • To highlight the importance of contraceptive counseling for transgender individuals undergoing GAHT.
  • To review the known and unknown effects of GAHT on fertility and contraception in transgender men and women.
  • To emphasize the need for further research in this area.

Main Methods:

  • Literature review on the effects of GAHT on fertility and contraception in transgender populations.
  • Analysis of existing studies on testosterone use in transgender men and estrogen use in transgender women.
  • Identification of knowledge gaps regarding reproductive health in transgender individuals.

Main Results:

  • Testosterone therapy in transgender men can lead to amenorrhea but does not guarantee anovulation, with reported unintended pregnancies.
  • Current contraceptive options for transgender men have pros and cons, with limited research on their use.
  • The impact of GAHT on fertility in transgender women is less understood, with estrogen causing sperm suppression but unclear pregnancy protection.

Conclusions:

  • Transgender individuals require comprehensive counseling on contraception and potential fertility effects before and during GAHT.
  • Testosterone therapy is not a reliable contraceptive method for transgender men.
  • More research is urgently needed to inform effective contraceptive strategies for transgender populations undergoing GAHT.